North America Cell Line Development Market $2.7 bn by 2024: Graphical Research Inc. According to the Graphical Research new growth forecast report titled “North America Cell Line Development Market analysis based on Product, Source, Cell Line, Application, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024”, estimated to exceed USD 2.7 billion by 2024. Growing demand for monoclonal antibodies, technological advancements in cell line development equipment and growing number of cancer incidences will drive North America cell line development market. Rising vaccine production, growth of biotechnology industry and high healthcare expenditure will drive business growth.
Presence of dominant industry players in U.S. focusing on developing advanced cell line development products coupled with favorable regulatory structure and innovation in development of biologics due to patent expiration will drive North America cell line development market. However, concerns pertaining to stem cell research will hinder industry growth over the forecast timeframe. Reagent and media product segment accounted for largest market share in 2017 and is estimated to follow similar trend over the coming years due to its numerous applications in development of regenerative medicines, bio production, drug discovery, tissue engineering toxicity testing and research. U.S. Cell Line Development Market, By Product, 2013 – 2024 (USD Bn)
1|Page